|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Stock-based compensation | |||||
| Gain from change in fair value of warrant liabilities | |||||
| Depreciation | |||||
| Amortization of intangible assets | |||||
| Changes in operating assets and liabilities: | |||||
| Prepaid expenses and other current assets | |||||
| Operating lease right-of-use assets and liabilities | |||||
| Accounts payable and other accrued expenses | |||||
| Accrued development expense | |||||
| Accrued compensation and benefits | |||||
| Other liabilities | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchases of property and equipment | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from issuance of common stock upon exercise of stock options | |||||
| Proceeds from exercise of common stock warrants, net of exercise costs | |||||
| Proceeds from common stock offering, net of issuance costs | |||||
| 2025 ATM offering program costs | |||||
| Net cash (used in) / provided by financing activities | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of period | |||||
| Cash and cash equivalents at end of period | |||||
| Non-cash financing activities | |||||
| Purchases of property and equipment included in accounts payable | |||||
| Issuance of warrants resulting in recognition of warrant liabilities | |||||
| Derecognition of warrant liabilities upon exercise of warrants |
Loading...